Mdxhealth Sa (MDXH)
Nasdaq: MDXH · Services-Medical Laboratories · Herstal, BE · filing with the SEC since 2021
Who owns Mdxhealth Sa
As filed with the SECHolders of 5% or more
3
Bleichroeder LP holds 32% of Ordinary Shares, as its SCHEDULE 13D/A filed Oct 15, 2026 says.
Directors and officers
12
report now, of 12 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Bleichroeder LP
SCHEDULE 13D/A · filed Oct 15, 2026 · Ordinary Shares · 33.2% in Aug 14, 2026
Laurence W. Lytton
SCHEDULE 13G/A · filed Aug 17, 2026 · Ordinary Shares · 9.6% in Aug 13, 2026
Genomic Health, Inc.
SCHEDULE 13G/A · filed Jan 16, 2026 · Ordinary shares, no par value
AWM Investment Company, Inc.
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock, No Par Value · reported falling below 5%, from 10.3% in Feb 7, 2025
What MDXH reports owning in othersstakes of 5% or more, and other ties
Mdxhealth Sa reports no stake in another company in the record.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$1.0Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bednarski Eric | director | 0 | $0 | 0 | 1 | $1.0M |